Turnstone Biologics is a leading biotechnology company based in La Jolla, CA, dedicated to developing innovative therapies for the treatment and cure of solid tumors. With a focus on tumor infiltrating lymphocytes (TILs), Turnstone is pioneering next-generation TIL therapies to address the challenge of low numbers of tumor reactive T cells in patients. Their experienced team of leaders and innovators brings deep expertise in TILs, cell therapy, tumor immunology, and complex biologics development.
Under the leadership of President and CEO Dr. Sammy Farah, Turnstone is committed to advancing the field of cancer immunotherapy. With a distinguished Scientific Advisory Board and a seasoned management team, the company is focused on developing novel approaches to deliver on the promise of TILs and create curative immunotherapies for patients with solid tumors. Turnstone's mission is to make a significant impact in the fight against solid tumors and improve outcomes for patients.
Generated from the website